Correlation Between Brightsphere Investment and Bristol Myers
Can any of the company-specific risk be diversified away by investing in both Brightsphere Investment and Bristol Myers at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Brightsphere Investment and Bristol Myers into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Brightsphere Investment Group and Bristol Myers Squibb, you can compare the effects of market volatilities on Brightsphere Investment and Bristol Myers and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Brightsphere Investment with a short position of Bristol Myers. Check out your portfolio center. Please also check ongoing floating volatility patterns of Brightsphere Investment and Bristol Myers.
Diversification Opportunities for Brightsphere Investment and Bristol Myers
0.62 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Brightsphere and Bristol is 0.62. Overlapping area represents the amount of risk that can be diversified away by holding Brightsphere Investment Group and Bristol Myers Squibb in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bristol Myers Squibb and Brightsphere Investment is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Brightsphere Investment Group are associated (or correlated) with Bristol Myers. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bristol Myers Squibb has no effect on the direction of Brightsphere Investment i.e., Brightsphere Investment and Bristol Myers go up and down completely randomly.
Pair Corralation between Brightsphere Investment and Bristol Myers
Given the investment horizon of 90 days Brightsphere Investment is expected to generate 2.21 times less return on investment than Bristol Myers. But when comparing it to its historical volatility, Brightsphere Investment Group is 1.76 times less risky than Bristol Myers. It trades about 0.1 of its potential returns per unit of risk. Bristol Myers Squibb is currently generating about 0.12 of returns per unit of risk over similar time horizon. If you would invest 79,600 in Bristol Myers Squibb on October 4, 2024 and sell it today you would earn a total of 20,289 from holding Bristol Myers Squibb or generate 25.49% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
Brightsphere Investment Group vs. Bristol Myers Squibb
Performance |
Timeline |
Brightsphere Investment |
Bristol Myers Squibb |
Brightsphere Investment and Bristol Myers Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Brightsphere Investment and Bristol Myers
The main advantage of trading using opposite Brightsphere Investment and Bristol Myers positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Brightsphere Investment position performs unexpectedly, Bristol Myers can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bristol Myers will offset losses from the drop in Bristol Myers' long position.The idea behind Brightsphere Investment Group and Bristol Myers Squibb pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Bristol Myers vs. Novartis AG | Bristol Myers vs. Bayer AG | Bristol Myers vs. Astellas Pharma | Bristol Myers vs. Roche Holding AG |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Other Complementary Tools
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Bonds Directory Find actively traded corporate debentures issued by US companies |